Published in Cancer Weekly, November 11th, 2003
The data was presented at a satellite symposium at the American College of Gastroenterology 2003 Annual Conference. PreGen-Plus, Exact Sciences' DNA-based stool test, was four times more sensitive than the most widely used fecal occult blood test (Hemoccult II) for the detection of colon cancer in an average-risk, asymptomatic population.
Data in the population studied indicated a point sensitivity for FOBT of 13% and a point...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.